Cador M, Dulluc J, Mormède P
Laboratoire de Psychobiologie des Comportements Adaptatifs, INSERM U259, INRA, Université de Bordeaux II, France.
Neuroscience. 1993 Oct;56(4):981-8. doi: 10.1016/0306-4522(93)90144-5.
In the present experiments, we investigated the influence of chronic modifications of circulating levels of corticosterone on the locomotor response to amphetamine. Different groups of rats were adrenalectomized and implanted subcutaneously with pellets releasing different amounts of corticosterone (0-200 mg). A wide range of corticosterone concentrations was reached in order to saturate selectively either the type I (mineralocorticoid) or the type II (glucocorticoid) corticosteroid receptors. The locomotor response to d-amphetamine (1.5 mg/kg) was studied 10-14 days later. We found that adrenalectomy reduced the response to d-amphetamine by 33% and that a normal response was restored with pellets releasing physiological concentrations of corticosterone (50-mg pellets), and was potentiated in animals with pellets releasing high amounts of corticosterone mimicking chronic stress situations (200-mg pellets). The correlation between plasma corticosterone concentration, locomotor activity following d-amphetamine and thymus weight, which is a reliable indicator of glucocorticoid action, shows that the influence of the locomotor response to d-amphetamine administration is likely to be mediated via a type II receptor. Since the locomotor activating effect of peripheral administration of d-amphetamine has been shown to depend on the integrity of the dopaminergic innervation of the nucleus accumbens, the effect of d-amphetamine at different doses (0, 1, 3, 10 micrograms/microliter) injected directly into the nucleus accumbens was studied. The results demonstrated that removing the circulating corticosterone induced a similar decrease of the locomotor activity elicited by d-amphetamine injection in the nucleus accumbens. This response was restored in animals with the 50- and 200-mg pellets.(ABSTRACT TRUNCATED AT 250 WORDS)
在当前实验中,我们研究了循环中皮质酮水平的长期改变对苯丙胺运动反应的影响。将不同组的大鼠进行肾上腺切除术,并皮下植入释放不同量皮质酮(0 - 200毫克)的药丸。达到了广泛的皮质酮浓度范围,以便选择性地饱和I型(盐皮质激素)或II型(糖皮质激素)皮质类固醇受体。10 - 14天后研究对d - 苯丙胺(1.5毫克/千克)的运动反应。我们发现肾上腺切除术使对d - 苯丙胺的反应降低了33%,而释放生理浓度皮质酮(50毫克药丸)的动物恢复了正常反应,在释放大量皮质酮模拟慢性应激情况(200毫克药丸)的动物中反应增强。血浆皮质酮浓度、d - 苯丙胺后的运动活动与胸腺重量之间的相关性表明,对d - 苯丙胺给药的运动反应影响可能是通过II型受体介导的。由于已表明外周给予d - 苯丙胺的运动激活作用取决于伏隔核多巴胺能神经支配的完整性,因此研究了直接注射到伏隔核中不同剂量(0、1、3、10微克/微升)的d - 苯丙胺的作用。结果表明,去除循环中的皮质酮会导致伏隔核中d - 苯丙胺注射引起的运动活动类似程度的降低。在植入50毫克和200毫克药丸的动物中这种反应得以恢复。(摘要截断于250字)